nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A multiparametric approach to improve the prediction of response to immunotherapy in patients with metastatic NSCLC
|
Del Re, Marzia |
|
|
70 |
6 |
p. 1667-1678 |
artikel |
2 |
Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature
|
Meriggi, Fausto |
|
|
70 |
6 |
p. 1511-1517 |
artikel |
3 |
Anti-human CD99 antibody exerts potent antitumor effects in mantle cell lymphoma
|
Takheaw, Nuchjira |
|
|
70 |
6 |
p. 1557-1567 |
artikel |
4 |
Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy
|
Li, Qingsheng |
|
|
70 |
6 |
p. 1789-1796 |
artikel |
5 |
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer
|
Suárez, Gisela María |
|
|
70 |
6 |
p. 1735-1743 |
artikel |
6 |
Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review
|
Zhao, Zhe |
|
|
70 |
6 |
p. 1527-1540 |
artikel |
7 |
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
|
Di Noia, Vincenzo |
|
|
70 |
6 |
p. 1583-1592 |
artikel |
8 |
BRAF and MEK inhibition in melanoma patients enables reprogramming of tumor infiltrating lymphocytes
|
Peiffer, Lukas |
|
|
70 |
6 |
p. 1635-1647 |
artikel |
9 |
Circulating leukocyte–platelet complexes as a predictive biomarker for the development of immune-related adverse events in advanced non-small cell lung cancer patients receiving anti-PD-(L)1 blocking agents
|
Zamora, Carlos |
|
|
70 |
6 |
p. 1691-1704 |
artikel |
10 |
Comprehensive genomic and immunophenotypic analysis of CD4 T cell infiltrating human triple-negative breast cancer
|
Zhang, He |
|
|
70 |
6 |
p. 1649-1665 |
artikel |
11 |
CTLA4 promoter methylation predicts response and progression-free survival in stage IV melanoma treated with anti-CTLA-4 immunotherapy (ipilimumab)
|
Fietz, Simon |
|
|
70 |
6 |
p. 1781-1788 |
artikel |
12 |
Discovery of acquired molecular signature on immune checkpoint inhibitors in paired tumor tissues
|
Yoo, Shin Hye |
|
|
70 |
6 |
p. 1755-1769 |
artikel |
13 |
Efficacy of immune checkpoint inhibitors in elderly patients aged ≥ 75 years
|
Petrelli, Fausto |
|
|
70 |
6 |
p. 1777-1780 |
artikel |
14 |
Epstein–Barr virus recruits PDL1-positive cells at the microenvironment in pediatric Hodgkin lymphoma
|
Jimenez, O. |
|
|
70 |
6 |
p. 1519-1526 |
artikel |
15 |
Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
|
Yi, Ming |
|
|
70 |
6 |
p. 1705-1719 |
artikel |
16 |
Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers
|
Liu, Qingzhu |
|
|
70 |
6 |
p. 1721-1733 |
artikel |
17 |
Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumab
|
Kim, Nalee |
|
|
70 |
6 |
p. 1593-1603 |
artikel |
18 |
Inflammatory cell-associated tumors. Not only macrophages (TAMs), fibroblasts (TAFs) and neutrophils (TANs) can infiltrate the tumor microenvironment. The unique role of tumor associated platelets (TAPs)
|
Dymicka-Piekarska, Violetta |
|
|
70 |
6 |
p. 1497-1510 |
artikel |
19 |
Let-7d inhibits intratumoral macrophage M2 polarization and subsequent tumor angiogenesis by targeting IL-13 and IL-10
|
Su, Boxing |
|
|
70 |
6 |
p. 1619-1634 |
artikel |
20 |
Melanoma cells can be eliminated by sialylated CD43 × CD3 bispecific T cell engager formats in vitro and in vivo
|
de Jong, G. |
|
|
70 |
6 |
p. 1569-1581 |
artikel |
21 |
microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy
|
Galore-Haskel, Gilli |
|
|
70 |
6 |
p. 1541-1555 |
artikel |
22 |
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy
|
Park, Changhee |
|
|
70 |
6 |
p. 1605-1617 |
artikel |
23 |
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors
|
Takamori, Shinkichi |
|
|
70 |
6 |
p. 1745-1753 |
artikel |
24 |
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro
|
Presti, Mario |
|
|
70 |
6 |
p. 1771-1776 |
artikel |
25 |
The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations
|
Willvonseder, Barbara |
|
|
70 |
6 |
p. 1679-1689 |
artikel |